InflaRx N.V. (IFRX) vs Lexeo Therapeutics, Inc. (LXEO)
InflaRx N.V. and Lexeo Therapeutics, Inc. are both Biotechnology companies. InflaRx N.V. and Lexeo Therapeutics, Inc. are of similar size ($284.4M and $278.3M). Across the 11 metrics below, InflaRx N.V. leads on 7 and Lexeo Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | IFRX | LXEO | Biotechnology median |
|---|---|---|---|
| Gross margin | (26,762.42%) | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (38.71%) | (46.76%) | (57.72%) |
| Return on assets | (32.75%) | (40.50%) | (49.22%) |
| Return on invested capital | 0.00% | (253.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack